Bence Patocskai1,2, Namsik Yoon2,3, Charles Antzelevitch2,4,5. 1. Department of Pharmacology and Pharmacotherapy, University of Szeged Faculty of Medicine, Szeged, Hungary. 2. Masonic Medical Research Laboratory, Utica, New York. 3. Department of Cardiology, Chonnam National University Hospital, Gwangju, Republic of Korea. 4. Lankenau Institute for Medical Research, Wynnewood, Pennsylvania. 5. Lankenau Heart Institute, Wynnewood, Pennsylvania.
Abstract
OBJECTIVES: This study sought to test the hypothesis that elimination of sites of abnormal repolarization, via epicardial RFA, suppresses the electrocardiographic and arrhythmic manifestations of BrS. BACKGROUND: Brugada syndrome (BrS) is associated with ventricular tachycardia and ventricular fibrillation leading to sudden cardiac death. Nademanee et al. reported that radiofrequency ablation (RFA) of right ventricular outflow tract epicardium significantly reduced the electrocardiogram and arrhythmic manifestations of BrS. These authors concluded that low-voltage fractionated electrogram activity and late potentials are caused by conduction delay within the right ventricular outflow tract and that the ameliorative effect of RFA is caused by elimination of this substrate. Szel et al. recently demonstrated that the abnormal electrogram activity is associated with repolarization defects rather than depolarization or conduction defects. METHODS: Action potentials (AP), electrograms, and pseudoelectrocardiogram were simultaneously recorded from coronary-perfused canine right ventricular wedge preparations. Two pharmacological models were used to mimic BrS genotype: combination of INa blocker ajmaline (1 to 10 μM) and IK-ATP agonist pinacidil (1 to 5 μM); or combination of Ito agonist NS5806 (4 to 10 μM) and ICa blocker verapamil (0.5 to 2 μM). After stable induction of abnormal electrograms and arrhythmic activity, the preparation was mapped and epicardial RFA was applied. RESULTS: Fractionated low-voltage electrical activity was observed in right ventricular epicardium but not endocardium as a consequence of heterogeneities in the appearance of the second upstroke of the epicardial AP. Discrete late potentials developed as a result of delay of the second upstroke of the AP and of concealed phase 2 re-entry. Epicardial RFA of these abnormalities normalized Brugada pattern and abolished arrhythmic activity, regardless of the pharmacological model used. CONCLUSIONS: Our results suggest that epicardial RFA exerts its ameliorative effect in the setting of BrS by destroying the cells with the most prominent AP notch, thus eliminating sites of abnormal repolarization and the substrate for ventricular tachycardia ventricular fibrillation.
OBJECTIVES: This study sought to test the hypothesis that elimination of sites of abnormal repolarization, via epicardial RFA, suppresses the electrocardiographic and arrhythmic manifestations of BrS. BACKGROUND:Brugada syndrome (BrS) is associated with ventricular tachycardia and ventricular fibrillation leading to sudden cardiac death. Nademanee et al. reported that radiofrequency ablation (RFA) of right ventricular outflow tract epicardium significantly reduced the electrocardiogram and arrhythmic manifestations of BrS. These authors concluded that low-voltage fractionated electrogram activity and late potentials are caused by conduction delay within the right ventricular outflow tract and that the ameliorative effect of RFA is caused by elimination of this substrate. Szel et al. recently demonstrated that the abnormal electrogram activity is associated with repolarization defects rather than depolarization or conduction defects. METHODS: Action potentials (AP), electrograms, and pseudoelectrocardiogram were simultaneously recorded from coronary-perfused canine right ventricular wedge preparations. Two pharmacological models were used to mimic BrS genotype: combination of INa blocker ajmaline (1 to 10 μM) and IK-ATP agonist pinacidil (1 to 5 μM); or combination of Ito agonist NS5806 (4 to 10 μM) and ICa blocker verapamil (0.5 to 2 μM). After stable induction of abnormal electrograms and arrhythmic activity, the preparation was mapped and epicardial RFA was applied. RESULTS: Fractionated low-voltage electrical activity was observed in right ventricular epicardium but not endocardium as a consequence of heterogeneities in the appearance of the second upstroke of the epicardial AP. Discrete late potentials developed as a result of delay of the second upstroke of the AP and of concealed phase 2 re-entry. Epicardial RFA of these abnormalities normalized Brugada pattern and abolished arrhythmic activity, regardless of the pharmacological model used. CONCLUSIONS: Our results suggest that epicardial RFA exerts its ameliorative effect in the setting of BrS by destroying the cells with the most prominent AP notch, thus eliminating sites of abnormal repolarization and the substrate for ventricular tachycardia ventricular fibrillation.
Authors: José M Di Diego; Serge Sicouri; Rachel C Myles; Francis L Burton; Godfrey L Smith; Charles Antzelevitch Journal: J Mol Cell Cardiol Date: 2012-11-09 Impact factor: 5.000
Authors: David S Park; Marina Cerrone; Gregory Morley; Carolina Vasquez; Steven Fowler; Nian Liu; Scott A Bernstein; Fang-Yu Liu; Jie Zhang; Christopher S Rogers; Silvia G Priori; Larry A Chinitz; Glenn I Fishman Journal: J Clin Invest Date: 2014-12-15 Impact factor: 14.808
Authors: Anna Sarcon; Henry Hsia; Pieter G Postema; Arthur A M Wilde; Bence Patocskai; José M Di Diego; Charles Antzelevitch; Melvin Scheinman Journal: JACC Clin Electrophysiol Date: 2021-02
Authors: Franziska Sendfeld; Elisabet Selga; Fabiana S Scornik; Guillermo J Pérez; Nicholas L Mills; Ramon Brugada Journal: Int J Mol Sci Date: 2019-04-29 Impact factor: 5.923
Authors: José M Di Diego; Bence Patocskai; Hector Barajas-Martinez; Virág Borbáth; Michael J Ackerman; Alexander Burashnikov; Jérôme Clatot; Gui-Rong Li; Victoria M Robinson; Dan Hu; Charles Antzelevitch Journal: PLoS One Date: 2020-11-24 Impact factor: 3.240
Authors: Wener Li; Michael Stauske; Xiaojing Luo; Stefan Wagner; Meike Vollrath; Carola S Mehnert; Mario Schubert; Lukas Cyganek; Simin Chen; Sayed-Mohammad Hasheminasab; Gerald Wulf; Ali El-Armouche; Lars S Maier; Gerd Hasenfuss; Kaomei Guan Journal: Front Cell Dev Biol Date: 2020-10-22